Survival bias is a potential problem when subjects are lost to follow-up, and this selection issue may arise in a wide range of biomedical studies. Controlling for the bias is difficult because subjects may be lost due to unmeasured factors. This article presents a two-step method that adjusts for survival bias in the proportional hazards model, even when unmeasured factors influence survival. First, we fit a standard Cox proportional hazards model to estimate a naive marginal hazard ratio. Then, this estimate is adjusted to account for survival bias. The approach is based on frailty theory, and the unobserved risk factors are assumed to follow a parametric distribution in the population. Importantly, we are able to estimate the parameters of this distribution using published, real-life data on familial risks. An approach that is valid for instrumental variable analysis with proportional hazard models is also presented. Finally, these methods are applied to real data in a crude example, assessing the effect of alcohol on mortality.
Introduction
A fundamental issue in biomedical studies is survival bias. This bias may arise if an exposure is introduced at time t 0 , but the analysis is performed on subjects at a later time t > t 0 . Between t 0 and t, people may have been lost to follow-up. In observational studies, the survival bias often occurs because exposures are present before the subjects are recruited to the study, and the surviving sample is not necessarily representative of the pre-exposure population. Even in randomised controlled trials, the same bias may arise when the treatment effect is assessed in individuals at a time t later than randomisation at t 0 (Hernán, 2010; Greenland, 1996; Aalen and others, 2015; Stensrud and others, 2017; McNamee, 2017) . In such scenarios, causal inference is not straightforward.
Intuitively, individuals who are lost to follow-up are expected to be the most frail. More precisely, the hazard of an event may be heterogeneously distributed across individuals, and the subjects who are lost before time t may have higher average hazard (Vaupel and others, 1979; others, 2008, 2015) . In some scenarios we have a good understanding of the factors that determine the individual hazards. Then, we may adjust for survival bias by including these factors in our model, e.g. by performing inverse probability weighting (Hernán and Robins, 2016) . However, the heterogeneity may often be due to unobserved factors, and using measured factors will not be sufficient. In such situations, frailty models have been used to account for the variation in susceptibility to disease (Vaupel and others, 1979; Moger and others, 2004; Haugen and others, 2009; Moger and Aalen, 2008; Moger and others, 2004) . Unfortunately, specifying the parameters of the frailty distribution is not obvious, in particular when analysing data on independent individuals.
The Cox proportional hazards model is fundamental to the study of time-to-event outcomes in medicine and epidemiology. This model is particularly appealing because the effect of an exposure is summarised in a simple summary statistic, the hazard ratio (HR), without modelling the hazard rates per se. To estimate the HR, we must follow subjects over a time period, and the HR may often be interpreted as an incidence ratio. However, the causal understanding of the HR is not straight-forward (Aalen and others, 2015; Hernán and Robins, 2016; Hernán, 2010; Greenland, 1996) . One issue is the concept of survival bias. The HR from a Cox proportional hazards model is also non-collapsible, i.e. generally the marginal HR cannot be expressed as a weighted average of conditional HRs. If we consider an outcome under two Cox proportional models that includes different covariates, only one of these models can be valid (Ford and others, 1995) .
This article explores the causal interpretation of the HR. First, I describe a method to adjust for survival bias in proportional hazards models, even when unobserved factors are present. The strategy consists of two steps: 1) a standard Cox proportional is fitted to obtain a marginal HR, and 2) this HR is adjusted to account for survival bias, using frailty theory. Importantly, the method allows us to use published summary data on familial risks to find the frailty distribution, and thereby obtain estimates that are unaffected by survival bias.
The approach is extended to instrumental variable (IV) analyses with time to event outcomes. This is important because such analyses, e.g. Mendelian Randomisation (MR), hold the potential to reveal causal effects, but they also seem to be particularly prone to survival bias: MR studies rely on genetic variants that are carried from conception, but subjects are often included into these studies in late adulthood. Hence, subjects will often be lost to follow up. Unfortunately, this issue seems to be rarely addressed in real life MR studies. Until recently, MR methods for timeto-event outcomes have been lacking. Applied researchers have reported results without a formal justification or by considering survival outcomes to be binary (Boef and others, 2015; Almeida and others, 2014; Postmus and others, 2015; Burgess, 2015; Kamstrup and others, 2009; Lango Allen and others, 2010; Dehghan and others, 2007) . Tchetgen and others (2015) formally derived an IV method based on the Aalen additive hazards model, and a more general approach has already been suggested (Martinussen and others, 2016) . For the Cox proportional hazards model, which seems to be preferred by applied researchers, the current methods are only valid for rare outcomes with time-constant effects of the instrument on the exposure (Tchetgen and others, 2015) . This article suggest an IV approach for common outcomes, allowing for a time-varying effect of the instrument under certain restrictions.
Finally, this strategy is applied to real data in a crude example, assessing the effect of alcohol on mortality. The calculations emphasise that standard methods may yield effect measures that are considerably biased. In particular, marginal HRs may often be underestimates of the causal HRs.
Modelling the unobserved heterogeneity
There is a well-developed framework for frailty modelling in survival analysis (Aalen and others, 2008) . The frailty denotes the unobserved heterogeneity that influences the event times. This article uses ideas from frailty theory to model the unobserved causes of an event. In particular, we will consider a natural extension of the Cox proportional hazards model, in which the hazard rate in an individual is determined by an individual variable multiplied with a basic rate (Vaupel and others, 1979) .
We will start with a simple causal structure, displayed in Figure 1 . We are interested in the effect of a binary exposure X (taking values 0 and 1) on outcome Y . Specifically, our Y is a survival outcome, and the effect measure of interest is the HR, which requires us to evaluate subjects over a time interval [t 1 , t 1 + δ]. We observe individuals conditioning on survival until time t 1 (Hence the node S in Figure 1 ). There is an unknown factor U that also influences the event times.
Let h(t) denote the hazard rate at time t, and let h X=x (t) denote the hazard rate when X (possibly contrary to fact) is set to value x. Analogous to the original formulation by Vaupel and others (1979), we assume that the event time is described by the causal hazard function
where h 0 (t) is the baseline hazard, r is the causal HR of exposed to X conditional on U , and k(U ) is the effect of U , i.e. a merge of unknown factors. In this scenario, a proportional hazards model that omits U cannot correctly describe events generated from Equation 1 (Ford and others, 1995) . However, we can model k(U ), and ultimately obtain unbiased estimates of the conditional causal hazard ratio r. To do this, we will first obtain an estimate of the HR from the Cox proportional model that omits U . Then, we will adjust this estimate using the model of k(U ), which is based on independent data on familial recurrence risks.
Using familial data to find the variance of k(U )
Assume that k(U ) has a distribution in the population, and without loss of generality we let E(k(U )) = 1. Under these assumptions, we shall find the variance of k(U ) using published data on familial risks. To do this, we assume that U is shared among family members. This assumption can be relaxed if we rather use data on twin pairs; rather than assuming a shared risk among all family members, we may e.g. assume that monozygotic twins share U . We consider a survival outcome, and let T be the time of event Y for an individual. We define S(t) = P(T > t), i.e. the survival probability unconditional on U and X. The cumulative baseline hazard is H 0 (t) = t o h 0 (t)dt. Let T i and T j denote the time of event for individuals i and j who are monozygotic co-twins. Assuming X = 0, i.e. by only studying the unexposed, we define the familial recurrence risk at time t (FRR(t)), which is the relative risk of surviving until time t, given a co-twin lived longer than t
where L denotes the Laplace transform of k(U ). Importantly, estimates of FRRs are reported for a wide range of diseases and conditions. Hence, finding published estimates of the FRR will often be feasible in real life. Next we will show how Equation (2) enables us to find the variance of k(U ), assuming that k(U ) has particular parametric distributions.
Analytic results for the power variance function distributions
Assume that the distribution of k(U ) belongs to the large class of power variance function (PVF) distributions, which e.g. includes the gamma distribution, the inverse Gaussian distribution, the (compound) Poisson distribution and the Hougaard distributions. Similar to Aalen and others (2008), we express the expected value, variance and Laplace transform of the PVF family as
where ν > 0, ρ > −1 and mρ > 0. Throughout this article, we will only consider PVF distributions with mean equal to 1, i.e. E(k(U )) = 1. Hence, from Expression (3) we immediately obtain
The survival function under a PVF distribution is
We can now use Expressions (4) and (5) to find VAR(k(U )) under a particular PVF distribution. To do this, we use the relation between ν, ρ and m for that particular distribution.
Calculations for the gamma distribution
To illustrate, we consider the gamma distribution. This is probably the most frequently used distribution in frailty theory, and it is member of the PVF family. Using the notation in Equations (3), (4) and (5), the distribution arises when ρ → ∞ and m → 0 such that ρm → η > 0. Here, η is a shape parameter of the gamma distribution, but since E(k(U )) = η ν = 1, we have that ν = η. The Laplace transform of the gamma distribution with mean equal to 1 can be simplified to (Aalen and others, 2008)
We may now simplify Expression (5) to
and Equation (6) also allows us to simplify FRR(t) to
We use Equation (7) to express H 0 (t) as a function of S(t|X = 0) and ν
Finally, we can replace H 0 (t) in Expression (8) by the right side of Expression (9), and to find ν we can numerically solve
for a particular time point t = t 1 . When ν is derived, we are able to specify the variance of a gamma distributed k(U ). The same logic can be used for other PVF distributions (see the Appendix for R scripts that implement these methods numerically). Importantly, we are using the unexposed individuals, i.e. those who are characterised by X = 0. If Pr(X = 1) is small or the effect of X on Y is minor, we may use data from the whole population as an approximation.
We have now seen how the effect of U can be approximated by using information on FRR(t 1 ) and S(t 1 ) at a particular time t 1 . In the next section, I will describe how the information on k(U ) can be used to obtain estimates of HRs r with a causal interpretation. In addition to the information on k(U ), this requires an estimate of the marginal HR among survivors at a specific time t 1 , which is approximated by a Cox proportional hazards estimate in an interval [t 1 , t 1 + δ].
Using the marginal HR to estimate the causal HR
We continue to study the PVF family. Assume that our data are generated by a proportional hazards model as in Equation (1), and let r mar (t) denote the marginal HR among survivors at time t. Let r denote the causal HR conditional on U , which is assumed to be constant. Then, r mar at time t has a simple expression (Aalen and others, 2008) r mar (t) = r 1 +
which means that r mar (t)
We assume that ν is derived by the approach in Section 2.2, e.g. using family or twin data. The marginal HR at a particular time t 1 is approximately derived from a Cox proportional hazards model in an interval [t 1 , t 1 + δ]. For the gamma distribution, we have that m → 0. Hence, for the gamma distribution we can find r analytically by solving
for a particular point t = t 1 , where we use Expression (9) to find H 0 (t). For the inverse Gaussian distribution, we have that m=-0.5, and we can obtain r analytically by solving a quadratic equation
For other distributions in the PVF class, we may solve Equation (12) with respect to r numerically.
We have now described a proportional hazards model that adjusts for selection bias due to differences in survival. The adjustment is based on family (twin) studies that quantify recurrence risk, given a family member (co-twin) has a particular characteristic. In contrast to the biased marginal HR, we are able to derive an estimate with a causal interpretation: We obtain the causal HR, r, conditioning on U . Confidence intervals of r can be found numerically, as suggested in Appendix A. In Appendix B, a simulation study of plausible scenarios was performed, in which the adjusted 95% confidence intervals obtained approximately 95% coverage of the true r in all scenarios. Indeed, the simulations suggest that approach obtains sensible estimates in plausible scenarios.
In applied settings, We may expect a slight bias towards a null effect because because the marginal HR at t 1 is approximated by a Cox proportional hazards estimate in [t 1 , t 1 + δ], as suggested in Section 2.2.1. This means that we adjust for the impact of U until t 1 , but we do not adjust for the effect of U during follow up [t 1 , t 1 + δ]. In the simulations in Appendix B, t 1 = 50 was much larger than δ = 2, and the bias was negligible. However, similar to McNamee (2017), we may adjust for such bias by plugging in t 1 + t median rather than t 1 into the suggested adjustment formulas.
2.3.1
The HR is not required to be time-constant Hitherto, we have described r to be time-constant. However, the results in this section does not require r to be constant for all times t. Indeed, r must be constant in the follow-up period [t 1 , t 1 +δ], as usually assumed in Cox proportional hazards regression. Before follow-up at t 1 , the conditional HR, say r t<t1 (t), does not need to be time-constant. Rather, the total contribution of r t<t1 (t) until t 1 must be equal to r. More formally, let the constant HR in [t 1 , t 1 + δ] be defined as r [t1,t1+δ] . Then we require that
The right side of Equation (14) is an average of r t<t1 (t) weighted by the baseline hazard. This result is formally shown in the Appendix.
When is survival bias an issue?
We would expect that the magnitude of survival bias varies with (i) time, (ii) the size of the observed FRR and (iii) the parameterisation of the frailty distribution. We shall consider some scenarios, using the derivations in Sections 2.1-2.3. First, Equation (11) shows that the bias increases with t. In particular, when t → ∞, we have that r mar (t) → r −m . For the gamma distribution, m → 0, and r mar (t) → 1. Hence, the marginal HR will be attenuated towards a null-effect (Aalen and others, 2008). For some conditions, it may be that only a fraction of the population is susceptible, e.g. for a particular disease. In these scenarios, the compound Poisson model is convenient, because it allows for a non-susceptible fraction. Interestingly, for the compound Poisson distribution, m > 0, and
which means that we eventually will observe r mar with the opposite sign of r. This may have important implications: The marginal HR is not only a biased estimate of r, but it may also be invalid for hypothesis testing of an effect of r. This seems to be under-appreciated (Burgess, 2015) . Second, a large FRR(t), yields a large variation in risk between individuals (Valberg and others, 2017). Intuitively, we may also think that a large variation in risk leads to larger survival bias. To perform a numerical evaluation of the bias, we assume that a population is assessed at time t 1 . Let S(t 1 ) = 0.9, i.e. 10% are lost to follow up. We will study the relation between r and r mar (t 1 ) for different values of the FRR(t 1 ) (here defined as the risk of event Y before t 1 , given a co-twin is affected). In Figure 2 , we display r as a function of the FRR(t 1 ) when r mar (t 1 ) = 1.5. For a fixed r mar (t 1 ), we see that r increases exponentially with FRR(t 1 ). The plotted values of FRR(t 1 ) are not implausible in real life, in particular most common cancers are characterised by sibling recurrence risks of 2 and larger (Valberg and others, 2017; Hemminki and others, 2001) .
Extension to IV estimates
Instrumental variable (IV) approaches may be useful to identify causal relations. To find the effect of an exposure on an outcome, these techniques rely on an additional variable, the instrument. An instrument must satisfy the following assumptions to obtain unbiased effect estimates (Didelez and Sheehan, 2007; Smith and Ebrahim, 2004, 2003) :
• The instrument influences the exposure.
• The only pathway leading from the instrument to the outcomes goes through the exposure.
• The instrument is independent of any unmeasured factor that confounds the exposureoutcome relation.
In principle, the instrument could be binary, categorical or continuous. In the biomedical literature, the number of analyses based on IVs are increasing. Mendelian Randomisation (MR) studies are particularly popular, and such analyses rely on genetic variants as instruments. The genetic instruments appear in the literature as binary (i.e. the absence or the presence of a particular gene), discrete (a sum of different genetic variants) or continuous (e.g. a weighted function of several genetic variants) variables. There is, however, a temporal aspect of MR studies. The genetic variants are allocated at conception (t = 0), but the follow-up starts in adult life. Hence, survival bias is potentially a major issue because (i) there is often a large time-lag between perceived randomization at t 0 and follow-up, and (ii) MR holds the promise to reveal causal effects. A causal structure of an IV setting with survival outcomes is shown in Figure 3 . Here, S is survival until time t. In Section 2 we considered a simple binary exposure, but now we let the exposure A(t) be a time-varying continuous variable expressed as a function of the binary instrument G and the unknown component U . Let the data generating mechanism of A(t) be
( 15) where
We can obtain an unbiased estimate of A(t) given G, even if U is unknown. This estimate may not necessarily be derived from the dataset containing the outcome Y , but rather from a separate source.
Tchetgen and others (2015) recently suggested a proportional hazards strategy for IV analyses. This approach is only valid for rare outcomes due to the non-collapsibility of the hazard ratio. By modelling U , we will suggest a proportional hazards approach that is also valid for common outcomes. Similar to Tchetgen and others (2015), we will consider a proportional hazards model for the outcome Y h(t|U, A(t), G) = h(t|U, A(t))
In Expression (16), the first line is justified by the graph in Figure 3 , and the second line displays the assumed causal hazard function. Hence, β a denotes the causal effect of A(t) on Y , and this is the parameter that we ultimately aim to estimate in an MR study. Different from Tchetgen and others (2015), we allow A(t) be time-varying, but we restrict ψ(U ) to be time-constant. We will now suggest a method to estimate β a . This method relies on information about G and U , and we will use the results derived in Section 2.2.
Causal estimates in Mendelian randomisation studies.
To derive the estimate of β a , we imagine an intervention on G. We express the causal hazard rate when we intervene on G given U h G=g (t|U )
Hence, if (i) we intervene on G and (ii) U is known, we can uniquely identify A(t) G=g , which is the value of A(t) when G is set to g. Hence,
We introduce the parameter k(U ) such that k(U ) = e βaf (U ) ψ(U ). Similar to Section 2, we assume that k(U ) has a distribution in the population, and without loss of generality we let E(k(U )) = 1. Inserting k(U ) in Equation (17), we obtain
Let g 1 and g 2 be two variants of the instrument G. We can then express the causal HR under interventions on G
Now, we assume that individuals are followed up in the interval
For t < t 1 , we make similar assumption as in Section 2.3.1. Intuitively, we only require the total contribution of G to the hazard rate before t 1 to equal the constant contribution of
In mathematical terms, we define the time-constant HR in [t 1 , t 1 + δ] as HR cau [t1,t1+δ] . We also define h * (t) = h 0 (t)e βab0(t) , which is a baseline hazard function independent of G and U . Let
Equation (21) is equal to Equation (14) with r t<t1 and (iii) h * (t) with h(t).
We can now derive estimates of HR cau [t1,t1+δ] with the procedure in Section 2.2. Intuitively, we use the marginal HR between the subpopulations characterised by g 1 and g 2 in the follow-up period [t 1 , t 1 + δ], and this approach is identical to the procedure derived in Section 2. To make the idea explicit, we restate Expression (1)
Indeed, Expression (1) and (18) are identical if we replace (i) X by G and (ii) r with HR cau[t1,t1+δ] .
Deriving IV estimates of β a
We can solve Expression (19) for β a to find
Finally, we obtain an estimate of β a by plugging in the estimates of b g and HR caû
Expression (22) allows us to estimate β a (the causal effect of A on Y ). Hence, we have described an algorithm to obtain proportional hazards estimates for IV analysis that are adjusted for survival bias. To do this, we make (strong) assumptions about the effect of U . However, these assumptions may be justified by real life data. Notice that we do not require any explicit formulation of f (U ) or ψ(U ) except that k(U ) = e βaf (U ) ψ(U ). In contrast to Tchetgen and others (2015), we have not assumed that S(t|U, A(t), G) ≈ 1. Tchetgen and others (2015) required the rare events assumption, because they used standard Cox proportional hazards regression to find the marginal HR under a data generating mechanism similar to Expression (16). Hence, they assumed that the causal effect of the exposure conditional on U is proportional on the hazard scale, but they fitted a Cox proportional hazards model unconditional on U . Due to the non-collapsibility of the HR, the unconditional model is approximately correct if the event is rare, but incorrect for common outcomes. In this article, we do use the estimates from a (mis-specified) marginal proportional hazards model in an interval [t 1 , t 1 +δ] as an approximation to r mar (t 1 ). However, we do not require that the true, marginal HR can be correctly estimated by a Cox model at other times t, and we therefore do not need the rare events assumption.
We have considered the instrument G to be binary. A binary G may be reasonable when the instrument is a single gene, which initially was the standard approach for MR analyses. Today, however, most analysts use instruments that are combinations of multiple variants, usually quantified in a continuous genetic risk score (Burgess and Thompson, 2013) . This approach will often increase the power of the study, but it also requires all the single variants to satisfy the IV assumptions. Our approach is readily applicable to continuous instruments. Specifically, we then consider G to be a continuous variable, and Equation (15) thereby require G to have an additive effect on the Exposure A(t). The remaining derivations in Section 3 will all be valid for both a continuous and a binary G.
An illustrative example

The effect of alcohol on all-cause mortality
Almeida and others (2015) assessed the impact of alcohol consumption on all-cause mortality in old men (aged 70-89 years at baseline). To do this, they used genetic information on the Alcohol Dehydrogenase 1B (ADH1B) gene. A mutation in the gene leads to abnormal metabolism of ethanol, and carriers experience an unpleasant flushing while drinking. It is well-known that carriers consume less alcohol (Holmes and others, 2014) , and their reduced consumption is thought to be independent of confounding factors.
To avoid bias, the mortality HR between carriers and non-carriers of the genetic variant ADH1B (now, considered to be the exposure X in Figure 1 was estimated. After a follow-up period with median 8 years, Almeida and others (2014) derived a marginal HR r Almeida = 0.68 [0.54, 0.87] in carriers of the mutation. However, despite the strong marginal HR, subjects dying before 70-89 years were not included in their analysis, potentially leading to considerable survival bias. With the frailty methods, we may explore the magnitude of bias under explicitly defined model assumptions.
First, we consider the age of 75 years, which is approximately the mean age at baseline in the study by Almeida and others (2014) . Hence, we let r mar (75) = r Almeida . Then, we estimate the FRR of surviving 75 years or longer. Data from Scandinavian registries suggest that the relative probability of surviving 75 years, given a co-twin survived 75 years, is 1.27 in men (Hjelmborg and others, 2006) . Hence, we let FRR(75) = 1.27, assuming that the probability of surviving until 75 years is shared among monozygotic twins. To be strictly correct, we should have assessed the FRR(75) in non-carriers of the ADH1B mutation only, but we used the whole population as a crude estimate (in Scandinavians less than 4% carry the mutation, which is even rarer than in Australians (Linneberg and others, 2010) ).
According to Australian cohort life tables, 0.56 of Australian men survive until age 75 years (Rowland, 1997) . We assume a gamma distribution of k(U ), and we will use the values FRR(75) = 1.27, S(75) = 0.56 and r mar (75) = 0.68 [0.54, 0.87] to estimate the causal HR conditional on U . To highlight the magnitude of bias due to U , we first assume that FRR(75) and S(75) are true values without uncertainty, and we numerically solve Equation (10) to find ν = 0.846. Then, we use Equation (13) The 95% confidence interval is simply derived by plugging in the confidence limits of r mar (75) into Expression (13), and these estimates are valid due to the monotonic relation between r and r mar . We thereby assume that F RR(75) and S(75) are the true values in the population. Despite the strong r mar (75), the analysis suggests that r mar (75) is a conservative estimate of r. To derive this estimate, we have required that a weighted average of r(t) before follow up is equal to the the causal HR during follow up. In particular, this may allow for no effect of the variant during childhood, i.e. a conditional HR equal to 1, which seems plausible.
We may also obtain estimates of r by assuming other parameterisations of U . In Table 1 , we have shown results for 4 PVF distributions, using plug-in confidence intervals (95% CI plug-in). In this example, the results are robust to the parameterisation of k(U ). Intuitively, this is due to the relatively small F RR(t 1 ). However, this robustness does not necessarily apply to other scenarios (Stensrud and others, 2017), e.g. for larger F RR(t 1 ), as also seen in Figure 2 .
In real-life applications, it is not sufficient to account for the uncertainty in r mar . We must also consider the uncertainty in the other summary estimates that are used, i.e. FRR(t 1 ) and S(t 1 ). A numeric approach to derive such confidence intervals is described in Appendix A. We use this approach to account for the uncertainty in FRR (75) 
Calculation of IV estimates
In many MR analyses, only the association between the instrument and the outcome is reported (Burgess, 2015) . This may be due to the fact that deriving and causally interpreting IV estimates require some caution (VanderWeele and others, 2014), in particular for time to event outcomes (Burgess, 2015; Tchetgen and others, 2015) . Among other things, the genetic instruments are fixed throughout life, whereas the exposure may be a dynamic process. Indeed, we may interpret the results in Section 4.1 as an MR analysis, in which only the association between ADH1B (the instrument for alcohol) and all-cause mortality is included. Still, we may attempt to use the results from Almeida and others (2014) to derive IV estimates of the effect of alcohol consumption per se. To do this, we assume that Equation (15) describes the relation between ADH1B genotype (now denoted G) and alcohol drinking (A). More precisely, we assume that A(t) denotes the average alcohol consumption until time t. Then, we use data from independent sources to find the association between the ADH1B variant and alcohol consumption: It is reported that carrying the ADH1B variant reduces alcohol consumption by 17.2% (Holmes and others, 2014) . Australian men drink 14.2 unit per week in average (Australian Bureau of Statistics, 2015), so we let the true b g = −0.172 × 14.2. Assuming the linear model in Equation (15) and a gamma distributed k(U ), we can plug these numbers into Equation (22) This crude example suggests that the magnitude of survival bias may be considerable, in particular when there is an extreme selection of the oldest old. These particular IV results, however, should be interpreted with some caution. I have used summary data from three different sources to obtain the estimates. This illustrates how the procedure can be performed simply by using summary data. However, the results rely on the validity of each source of data. In particular, I have used data from monozygotic twins in Scandinavia to derive the FRR, whereas the study was performed in Australia. The effect of alcohol on mortality may also be non-linear in real life, e.g. that heavy drinking has a larger effect on mortality. Nevertheless, this example illustrates how the frailty approach can be applied to explore bias in IV settings. If specific estimates of F RR(t 1 ) and S(t 1 ) are unavailable, the suggested approach can still be performed as a sensitivity analysis: Applied researchers can check the sensibility to survival bias in their analysis by fitting frailty distributions with various values of F RR(t 1 ) and S(t 1 ).
Discussion
Survival bias will arise in the proportional hazards framework (Stensrud and others, 2017; others, 2008, 2015; Hernán, 2010) . This article suggests a method to adjust for the bias. By modelling the unobserved heterogeneity in disease risk, I explored the bias of conventional estimates in traditional time-to-event analyses as well as in IV calculations.
The proposed method is desirable because the unobserved heterogeneity is approximated by independent, summary data. These summary data may be collected from published articles, and the approach allows us to be less subjective when assessing the impact of unmeasured factors. Even if the particular example in Section 4 must be interpret with some caution, it suggests that the bias is an issue in real life.
More generally, this article highlights an important link between frailty models in survival analysis and causal inference: Interpreting estimates from Cox regressions may be challenging, e.g. due to non-collapsibility (Martinussen and Vansteelandt, 2013) and survival bias (Burgess, 2015) . However, by using frailty models, we find estimates with a causal interpretation: We identify the effect of the exposure conditional on the unobserved variable U . Intuitively, this is the effect of the exposure on the individual level.
When measured covariates are able to explain most of the heterogeneity in risk, the frailty approach may be less desirable than alternative approaches, e.g. inverse probability weighting. For many conditions, however, unmeasured factors may have considerable impact. In such situations, the frailty approach seems to be particularly attractive.
This article has considered proportional hazards models with mortality as outcome. The approach can be extended to other outcomes, e.g. particular diseases. For many diseases we will expect the impact of survival bias to be larger (Stensrud and others, 2017); we have shown that a larger variance in the unobserved heterogeneity yields a larger survival bias, and the FRR of several diseases is considerably larger than the FRR of longevity. For such outcomes, we may deal with survival bias by introducing correlated unknown factors (U 1 and U 2 ) for loss-to-follow up and the outcome, respectively, and thereafter use theory for separate, correlated frailty variables (see e.g. Aalen and others (2008) chapter 6.6). We aim to explore such analyses in future works.
By using family data, we adjust for the heterogeneity due to (unmeasured) genetic factors and shared environment. Using data from monozygotic twins is desirable, because such co-twins are genetically identical and expected to share several environmental factors. Nevertheless, non-shared environmental factors will not be captured in this approach. If such factors have large impact on the outcome, we may underestimate the magnitude of survival bias. When using twin data, we also implicitly assume that twins are representative of the general population. In particular, unmeasured factors that influence survival until follow-up at t 1 should be similarly distributed in twins as in the general population. Recently, it has been suggested that monozygotic twins live longer than the general population, but the difference was found to be modest Sharrow and Anderson (2016) . Indeed, higher survival in monozygotic twins would be likely to underestimate the size of survival bias: Intuitively, less individuals would be lost to follow-up, and there would be less differences between the exposure groups due to unmeasured factors.
The survival bias is a particular issue in MR studies, due to the long time lag between randomisation and follow up (Boef and others, 2015) . Interpreting IV estimates for time-to-event outcomes is not straightforward (Burgess, 2015) , but such methods have recently been developed, under explicitly defined assumptions. In particular, estimates from the Aalen additive model do not suffer from survival bias if the unobserved confounding is additive (Tchetgen and others, 2015; Martinussen and others, 2016; Li and others, 2015) . MacKenzie and others (2014) considered a Cox proportional hazards model with additive unobserved confounding, but it relies on some unrealistic assumptions (Tchetgen and others, 2015) . None of these approaches, however, have evaluated a multiplicative unobserved confounder, which seems to be desirable in the proportional hazards framework. 
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A Derivation of confidence intervals
To derive estimates of the causal hazard ratio r cau , we need to consider three estimates with uncertainty: 1) The marginal HR (r mar ), 2) The familial risk (twin recurrence risk) at time t 1 (F RR(t 1 )), and 3) The probability of surviving until t 1 (S(t 1 )). We assume that these estimates are derived from independent sources. Then, it is simple to derive confidence intervals of HR cau , using a numeric evaluation. Sincer mar is derived from a Cox model, we have that log(r mar ) is approximately normally distributed. Similarly,F RR(t 1 ) is estimated as a relative risk, and hence log(F RR(t 1 )) is approximately normally distributed. The estimate of survival until t 1 ,Ŝ(t 1 ), is approximately normally distributed without transformation. We can use this to find a numeric confidence interval, based on n simulated estimates 1. Let the estimate of r mar ber mar with 95% confidence interval [r mar,min ,r mar,max ]. Then, log(r mar )∼N log(r mar ), log(r mar ) − log(r mar,min ) Φ −1 (0.975)
where Φ −1 (c) is the inverse cumulative standard normal distribution. Hence, for each i in 1, 2, ..., n we draw log(r mar,i ) from this distribution.
Let the estimate of F RR(t
Then,
Hence, for each i in 1, 2, ..., n we draw log(F RR(t 1 ) i ) from this distribution.
Let the estimate of S(t
4. Finally, for each i in 1, 2, ..., n we obtain an estimate r cau,i by plugging the estimates in 1.-3. into the algorithm described in Section 2 in the main text. A (1 − α) confidence interval of r cau,i is found by using the 
B Simulations to verify the approach
A simulation algorithm was derived to check the validity of the causal estimates in Section 2. This algorithm consists of 3 steps, and the R code to implement the approach is attached. Below is a brief description of the approach in natural language.
Step 1. Simulate survival times and find the marginal HR.
• Select n 1 unexposed subjects. Each i in 1, 2, ..., n 1 is characterised by an individual frailty U i , and we randomly draw the variable k(U i ) ∼ Gamma(mean = 1, ν).
• Similarily, we select n 2 exposed individuals. For each j in 1, 2, ..., n 2 we randomly draw k(U j ) ∼ Gamma(1, ν).
• Let the causal hazard ratio of the exposure X conditional on U be r.
• Assume that the baseline hazard rate is constant, h 0 (t) = λ. To obtain survival times for each i, we first draw W i ∼ Uniform[0, 1]. Then we find the survival time
as suggested by Bender and others (2005).
• Similarly, for each j we draw W j ∼ Uniform[0, 1], and we find the survival time
• Assume follow up starts at t = t 1 .
• We then select the sets of individuals L 1 such that i ∈ L i iff S i > t 1 , and L 2 such that j ∈ L j iff S j > t 1 .
• To derive the marginal HR, we fit a Cox proportional hazards model to the subjects in L 1 and L 2 , using exposure X as the only covariate.
Step 2. Simulate twin recurrence risks.
• To estimate the twin recurrence risk, select n 3 unexposed twin pairs. This sample is independent of the sample in Step 1.
• For each twin pair m in 1, 2, ..., n 3 , we randomly draw the shared k(U m ) ∼ Gamma(1, ν).
• For each twin pair, we selected a random co-twin m 1 . We then find the overal risk of surviving until t 1 ,
where I(S i > t 1 ) is an indicator function taking value 1 if S i > t 1 and 0 otherwise.
• Let L 3 denote the set of survivors such that m 1 ∈ L 3 iff S m1 > t 1 . Denote the number of subjects in L 3 as n L3 . Then, we find the conditional probability of survival in m 2 given m 1 survived
• We estimate the twin recurrence risk
The standard errors are e.g. found using Wald estimators for relative risks.
Step 3. Simulate survival until time t 1 .
• To make the simulations realistic, let the life-time risk of disease be selected from a new sample.
• Select n 4 unexposed subjects.
• For each subject z in 1, 2, ..., n 4 , we randomly draw the k(U z ) ∼ Gamma(1, ν).
• Similar to Step 1 we find S z for each z. Then we simply estimate P r(S z > t 1 ) with standard confidence intervals, assuming a normal distribution.
Step 4. Simulate survival until time t 1 .
• Based on the confidence intervals derived from Part 1-3, we can find the confidence interval of the causal hazard ratio numerically. To do this, we use the strategy suggested in Appendix A.
B.1 Validation of particular scenarios
The simulation algorithm can be used to check the approach under particular scenarios. To illustrate, let the effect of the exposure X conditional on U be a hazard ratio r cau (t) = 0.80. Furthermore, let the distribution of k(U ) be characterized by mean= 1 and ν = 1 9 . The basic hazard rate is set to h 0 (t) = 0.002. Using the derivations in Section 2, we find that the exact value F RR(t 1 ) = 1.029 and S(t 1 |X = 0) = 0.931). This scenario was simulated 500 times. In each simulation, 10 6 unexposed subjects and 10 6 exposed subjects were included. Follow-up was initiated at t 1 = 50, i.e. only those who survived until the age of 50 were included. The duration of follow up was 1 year. This allowed for the calculation of marginal HR from a Cox proportional hazards model. The marginal estimates (r mar (t 1 )) were biased towards the null; Only 31.2% of the marginal 95% confidence intervals covered r cau . To obtain adjusted estimates, we used simulated data from an independent sample of 10 5 twin pairs, in which the F RR(50) was estimated. We also used independent sample of 10 6 subjects to estimate S(50). Then, adjusted estimates were obtained by the approach in Section 2, and confidence intervals were found by the approach in Appendix A. These adjusted estimates were better calibrated; 94.8 % of the adjusted 95% confidence intervals covered r cau . A summary of the simulations is found in Table B .1 (Scenario 1).
Similarly, two more extreme scenarios were also simulated (Table B .1, Scenario 2 and Scenario 3). In these scenarios, the same number of subjects were included for estimatingr mar (t 1 ), FRR(t 1 ) and S(t 1 ) as in Scenario 1. However, different values for r cau , h 0 (t) and ν were introduced. In these scenarios, the coverage of the confidence intervals forr mar (t 1 ) were close to 0, but the adjusted estimates showed coverage approximately 95%.
In all scenarios, the adjusted estimates (r adjusted (t 1 ) in 
C Generalising to non-constant hazard ratio
In the Derivations of Section 2, we described the causal HR r to be time-constant. We will now show that this assumptions can be relaxed. Let r [t1,t1+δ] denote the HR in the follow-up period, which is assumed to be time-constant, according to standard proportional hazards models. We shall see that the HR before t 1 , say r t<t1 (t), does not necessarily need to be constant in time. In the exposed population before follow-up at t 1 , the baseline hazard rate, i.e. the rate unconditional on U , is r t<t1 (t)h(t)
Let us define a weighted time-average of r t<t1 (t)
Rather than assuming a constant r, we can assume that
To see this formally, we describe the marginal hazard rate conditional on survival until time t 1 , h mar , using Equation (6.15) in Aalen and others (2008), which is valid for all PVF distributions. Assuming a constant r for all time points, the marginal hazard rate among the unexposed is
In the exposed group, assuming a constant r the marginal hazard rate is
Now, assume that the causal HR is defined as in Expression (24). Then, the hazard for the unexposed group remains unchanged, and the marginal hazard rate in the exposed group at t 1 is
which is equal to Expression (26). Hence, if we study subjects in [t 1 , t 1 + δ] under the more liberal assumption in Expression (24), results are identical to a situation in which r is constant for all t. This may be useful, e.g. in the example in Section 4.1. In particular we do not need to assume that the ADH1B variant influences the hazard rates in childhood and youth, i.e. before people start drinking. Rather, we only assume that the average conditional HR throughout life is equal to the conditional HR in [t 1 , t 1 + δ].
D Appendix: R code
######## F u n c t i o n s ######################## #Find V implements t h e d e r i v a t i o n s i n S e c t i o n 2 . 2 f o r t h e Gamma d i s t r i b u t i o n
observedHR findV <− function (FRR, S , from1=1e −30 , t o 1 =20 , l e n =30 , r r =2.10 , observedHR =1.23 , p l o t A n d P r i n t=F , nonStandard=F) { sequence <− seq ( from=from1 , t o=to1 , length . out=l e n ) r i g h t S i d e <− FRR * S^2 tryCatch ( { v <− uniroot ( combinedFRRS , S=S , r i g h t S i d e=r i g h t S i d e , i n t e r v a l=c ( 0 , t o 1
a u s a l R i s k R a t i o <− r e t u r n C a u s a l R i s k ( HRobs=observedHR , A=A, v=v ) i f ( p l o t A n d P r i n t==T) { plot ( r i g h t S i d e −output~sequence , ylim=c (min( 0 ,min( r i g h t S i d e −output ) ) , max( r i g h t S i d e −output ) ) , type = " l " , x l a b=" v a l u e ␣ o f ␣v" , y l a b="S^2 * FRR−output " ) abline ( a=0,b=0, col =1, l t y =2) print ( paste ( "The␣ v a r i a n c e ␣ v a l u e ␣ i s : ␣" , 1 /sequence [ index ] , " , ␣ with ␣ d i f f e r e n c e " , r i g h t S i d e −output [ index ] ) ) print ( c ( sequence [ index ] , A, r i s k R a t i o , c a u s a l R i s k R a t i o ) ) } return ( c a u s a l R i s k R a t i o ) } #combinedFRRS r e t u r n s e x p r e s s i o n ( 8 )
#f i n d V g e n e r a l e x t e n d s findV t o s e v e r a l f u n c t i o n s o f t h e PVF f a m i l y , i . e . t h e I n v e r s e Gaussian , t h e Compound P o i s s o n and t h e Hougaard Family o f d i s t r i b u t i o n s f i n d V g e n e r a l <− function (FRR, S , from1=1e −6, t o 1 =100 , l e n =20000 , invGaus=F , gamDist=F , comPois=F , Hougaard=F , nonSuscep =0.01 , mHougaard= −0.25 , r r =2.10 , observedHR =1.23 , p l o t A n d P r i n t=F) { s e q u e n c e 1 <− seq ( from=from1 , t o=to1 , length . out=l e n ) i f ( invGaus ) { m = −0.5 p <− s e q u e n c e 1 /m sequence <− cbind ( sequence1 , p , rep (m, length ( s e q u e n c e 1 ) ) ) } i f ( comPois ) { p = −log ( nonSuscep ) m <− s e q u e n c e 1 /p sequence <− cbind ( s equence1 , rep ( p , length ( s e q u e n c e 1 ) ) , m) } i f ( gamDist ) { p = 1 e13 ; m=1/p sequence <− cbind ( s equence1 , rep ( p , length ( s e q u e n c e 1 ) ) , rep (m, length ( s e q u e n c e 1 ) ) ) } i f ( Hougaard ) { m = mHougaard p <− s e q u e n c e 1 /m sequence <− cbind ( s equence1 , p , rep (m, length ( s e q u e n c e 1 ) ) ) } As <− apply ( sequence , 1 , f i n d A g e n e r a l , S=S ) vpmA <− cbind ( sequence , As ) r i g h t S i d e <− log (FRR) output <− apply (vpmA, 1 , f i n d D i f f e r e n c e G e n e r a l ,FRR=FRR) # o u t p u t [ 1 ] index <− which . min( abs ( output−r i g h t S i d e ) ) i f ( p l o t A n d P r i n t==T) { plot ( r i g h t S i d e −output~sequence [ , 1 ] , ylim=c (min( 0 ,min( r i g h t S i d e −output ) ) ,max( r i g h t S i d e −output ) ) , type = " l " , x l a b=" v a l u e ␣ o f ␣v" , y l a b="Ŝ 2 * FRR−output " ) aussieGamma <− sapply ( a u s s i e E s t i m a t e s , findV ,FRR = f r r A u s s i e , S=s A u s s i e , nonStandard = T, printV=T) a u s s i e I n v G a u s <− sapply ( a u s s i e E s t i m a t e s , f i n d V g e n e r a l , S=s A u s s i e ,FRR= f r r A u s s i e , invGaus = T, p l o t A n d P r i n t = T, t o 1 =1) a u s s i e H o u g a a r d <− sapply ( a u s s i e E s t i m a t e s , f i n d V g e n e r a l , S=s A u s s i e ,FRR= f r r A u s s i e , Hougaard = T, mHougaard = −0.125 , p l o t A n d P r i n t=T, t o 1 =1) aussieCPound <− sapply ( a u s s i e E s t i m a t e s , f i n d V g e n e r a l , S=s A u s s i e ,FRR= f r r A u s s i e , comPois=T, nonSuscep = 0 . 1 0 , p l o t A n d P r i n t=T)
#Find numeric c o n f i d e n c e i n t e r v a l s . set . s e e d ( 1 ) CIalmeidaExample <− r e p l i c a t e ( n=2e3 , numericCIgamma ( HRobsDerived=c ( 0 . 6 8 , 0 . 5 4 , 0 . 8 7 ) , R i s k D e r i v e d=c ( 0 . 5 6 , 0 . 5 6 , 0 . 5 6 ) , FRRderived=c ( 1 . 2 7 , 1 . 2 0 , 1 . 3 4 ) ) ) quantile ( CIalmeidaExample , c ( 0 . 0 2 5 , 0 . 5 , 0 . 9 7 5 ) ) CIalmeidaExampleInvGau <− r e p l i c a t e ( n=2e3 , numericCIpvf ( HRobsDerived=c ( 0 . 6 8 , 0 . 5 4 , 0 . 8 7 ) , R i s k D e r i v e d=c ( 0 . 5 6 , 0 . 5 6 , 0 . 5 6 ) , FRRderived=c ( 1 . 2 7 , 1 . 2 0 , 1 . 3 4 ) , invGausIn=T) ) quantile ( CIalmeidaExampleInvGau , c ( 0 . 0 2 5 , 0 . 5 , 0 . 9 7 5 ) ) CIalmeidaExampleComPois <− r e p l i c a t e ( n=2e3 , numericCIpvf ( HRobsDerived=c = h t . # The i n v e r s e i s H−1(H( t ) ) = H( t ) /h = t . I . e . an E x p o n e n t i a l d i s t r i b u t i o n .
# We w i l l now s i m u l a t e t h e h a z a r d f u n c t i o n # We can s i m u l a t e s u r v i v a l t i m e s s a m p l e S u r v i v a l T i m e <− function ( u , h0 , r =1){ u n i <− runif ( 1 ) out <− − log ( u n i ) / ( h0 * u * r ) return ( out ) } # Let us assume a Gamma d i s t r i b u t e d f r a i l t y # Let t h e r a t e=nu such t h a t t 1 i s t h e time t o s t a r t f o l l o w up # and t F o l l o w i s t h e number o f y e a r s under f o l l o w up time getConfidenceIntervalGamma <− function ( n=1e6 , h0 =0.002 , nu=1/ 9 , HRcau =0.8 , t 1 =50 , t F o l l o w = 2 ) { uExp <− rgamma( n , shape=nu , s c a l e = 1/nu ) uUnexp <− rgamma( n , shape=nu , s c a l e = 1/nu ) #Sample s u r v i v a l t i m e s timesExp <− sapply ( uExp , sampleSurvivalTime , h0=h0 , r=HRcau ) #summary ( timesExp ) timesUnexp <− sapply ( uUnexp , sampleSurvivalTime , h0=h0 , r =1) #summary # F i r s t , assume t h a t t h e s u r v i v a l i s known . Then we s i m p l y use E x p r e s s i o n 5 t o f i n d S St1 <− ( nu/ ( nu+h0 * t 1 ) )^nu # Furthermore , we use e x p r e s s i o n 8 t o f i n d t h e FRR( t 1 ) FRRt1 <− ( nu/ ( nu+2 * h0 * t 1 ) )^nu / St1^2 # Then we use t h e f u n c t i o n s t o f i n d t h e o b s e r v e d v a l u e adjustedCoxph <− findV ( S=St1 ,FRR=FRRt1 , observedHR=r e s u l t s N a i v e C o x p h , nonStandard = T, printV=F) #This l o o k s v e r y good . . . . ! return ( rbind ( r e s u l t s N a i v e C o x p h , adjustedCoxph ) ) } # Now, assume t h a t S and FRR a r e o n l y known w i t h u n c e r t a i n t y # Assume t h a t we o b t a i n e d n1 unexposed t w i n p a i r s from t h e same p o p u l a t i o n w i t h Us . f i n d E x p e c t e d S u r v i v a l <− function ( h , t , u , hr =1){ H <− h * t return ( exp(−H * u ) * hr ) } # Function t o f i n d t h e e x p e c t e d s u r v i v a l u n t i l time t 1 g e t C I g e n e r a l P o p u l a t i o n<− function ( n1In=n1 , nuIn=nu , h0In=h0 , t I n=t1 , h r I n= HRcau ) { u G e n e r a l P o p u l a t i o n <− rgamma( n1In , shape=nuIn , s c a l e = 1/nuIn ) probSurvivalGP <− f i n d E x p e c t e d S u r v i v a l ( h0In , t=tIn , hr =1,u= u G e n e r a l P o p u l a t i o n ) # Rather than hr=h r I n survivorsGP <− sapply ( probSurvivalGP , rbinom , n=1, s i z e =1) propGP <− prop . t e s t ( table ( survivorsGP ) ) estimatedPropGP <− 1−c ( propGP$ e s t i m a t e , propGP$ c o n f . i n t ) [ c ( 1 , 3 , 2 ) ] return ( estimatedPropGP ) } # Function t o f i n d t h e t w i n r e c u r r e n c e r i s k g e t C I t w i n R e c u r r e n c e R i s k <− function ( n1In=n1 , nuIn=nu , h0In=h0 , t I n=t1 , h r I n=HRcau ) { uTwinPairs <− rgamma( n1In , shape=nuIn , s c a l e = 1/nuIn ) p r o b S u r v i v a l <− f i n d E x p e c t e d S u r v i v a l ( h0In , t=tIn , hr =1,u=uTwinPairs ) # r a t h e r than hr=h r I n s u r v i v o r s T w i n P a i r s <− cbind ( sapply table ( s u r v i v o r s C o n d i t i o n a l ) ) ) r i s k R a t i o I n t e r v a l <− r i s k r a t i o . wald ( t a b l e M a t r i x ) $measure [ 2 , ] return ( r i s k R a t i o I n t e r v a l ) } # To c h e c k i f t h e c o n f i d e n c e i n t e r v a l i s c o r r e c t , we r e p e a t c a l c u l a t i o n s o f t h e o b s e r v e d HR, t h e FRR and t h e S u r v i v a l p r o b a b i l i t y c h e c k C I i s C o r r e c t <− function ( nInput=1e6 , nInputTwin=1e5 , h0Input =0.002 , nuInput=1/ 9 , HRcauInput =0.8 , t 1 I n p u t =50 , t F o l l o w I n p u t = 1 , k=1e4 ) { CIHRobserved <− getConfidenceIntervalGamma ( n=nInput , h0=h0Input , nu= nuInput , HRcau=HRcauInput , t 1=t1 In put , t F o l l o w = t F o l l o w I n p u t ) CIriskGP <− g e t C I g e n e r a l P o p u l a t i o n ( n1In=nInput , nuIn=nuInput , h0In= h0Input , t I n=t1 Inp ut , h r I n=HRcauInput ) C I r i s k T w i n s <− g e t C I t w i n R e c u r r e n c e R i s k ( n1In=nInputTwin , nuIn=nuInput , h0In=h0Input , t I n=t 1In pu t , h r I n=HRcauInput ) totalDraw <− r e p l i c a t e ( n=k , numericCIgamma ( HRobsDerived=CIHRobserved [ 1 , ] , R i s k D e r i v e d=CIriskGP , FRRderived=C I r i s k T w i n s ) ) C I t o t a l <− round ( quantile ( totalDraw , c ( 0 . 0 2 5 , 0 . 5 , 0 . 9 7 5 ) ) , 2 ) return ( c ( C I t o t a l , CIHRobserved [ 1 , ] ) ) } ######## E x p l i c i t i n p u t t o s i m u l a t i o n s #### # Each o u t p u t o b j e c t i n c l u d e s a matrix , i n which # each row has s i x e n t r i e s from a s i m u l a t i o n . # 1 . , 2 . and 3 . a r e t h e 2.5% , 50% and 97.5% p e r c e n t i l e s a f t e r a d j u s t m e n t . # # 4 . i s t h e n a i v e e s t i m a t e , w i t h c o n f i d e n c e bounds i n 5 . and 6 . set . s e e d ( 1 2 3 ) o u t p u t 1 s t 1 2 3 <− r e p l i c a t e ( n=5e2 , c h e c k C I i s C o r r e c t ( ) ) set . s e e d ( 1 2 3 ) output2nd123 <− r e p l i c a t e ( n=5e2 , c h e c k C I i s C o r r e c t ( nInput=1e6 , h0Input =0.003 , nuInput=1/ 1 5 , HRcauInput =0.7 , t 1 I n p u t =50 , t F o l l o w I n p u t = 1 , k =1e5 ) )
set . s e e d ( 1 2 3 ) o u t p u t 3 r d 1 2 3 <− r e p l i c a t e ( n=5e2 , c h e c k C I i s C o r r e c t ( nInput=1e6 , h0Input =0.00 , nuInput=1/ 5 , HRcauInput =0.7 , t 1 I n p u t =50 , t F o l l o w I n p u t = 1 , k=1 e5 ) ) X U Y S Figure 1 : Directed acyclic graph (DAG) of a simple scenario which may involve survival bias. X denotes an exposure, S denotes survival until a particular time point, Y is the outcome of interest and U is an unmeasured confounder. Figure 2: Hazard ratios plotted as a function of the FRR. We have assumed that the marginal hazard ratio conditional on survival is r mar (t = t 1 ) = 1.5 (dashed line). The solid lines show HR cau (t = t 1 ), i.e. the causal hazard ratio conditioning on U , assuming a gamma distribution (black), an inverse Gaussian distribution (red), a Hougaard distribution (green) and a compound Poisson distribution (blue). 
